3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Neoplasms
14
Lung Neoplasms
10
Colonic Neoplasms
10
Breast Neoplasms
9
Brain Neoplasms
6
Prostatic Neoplasms
4
Emergence Delirium
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Respiratory Aspiration
3
Rectal Neoplasms
3
Pituitary Neoplasms
3
Neoplastic Cells, Circulating
3
Hypoxia
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Agnosia
3
Supratentorial Neoplasms
2
Postoperative Complications
2
Patient Satisfaction
2
Pain, Postoperative
2
Pain
2
Ovarian Neoplasms
2
Melanoma
2
Liver Neoplasms
2
Leukemia
2
Delirium
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Tuberculosis, Pulmonary
1
Interventions
Esomeprazole
3
(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol
2
Tumor Necrosis Factor-alpha
1
Tetracycline
1
Propofol
1
Physical Examination
1
Omeprazole
1
Lansoprazole
1
Interleukin-10
1
Interleukin-1
1
Gastroscopy
1
Furazolidone
1
Endoscopy, Digestive System
1
Endoscopy
1
Dexlansoprazole
1
Clopidogrel
1
Bismuth
1
Berberine
1
Amoxicillin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Stomach Ulcer
×
Propofol
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled